Politics

FTC begins new discussion on noncompete agreements in work contracts across health care and the general economy.

Johns Hopkins analysts weigh in on national debate on health insurance and ways to pay for medical care.

New Medicare payment model aims to take down wasteful spending, but Congress and analysts point out potential problems.

An explainer of the new initiative to lower costs for patients while reining in pharmaceutical makers, PBMs and insurance companies.

Health insurance CEOs to be called in later this month; advocates call for changes to Medicare policies.

The revision preserves insurance coverage for all vaccines but shifts several shots to high-risk or shared decision-making categories as HHS promises new clinical trials.

Executive order recognizes potential medical use for cannabis, but there still are numerous details to work out.

A hidden cost shift is creating a new affordability crisis for patients.

New polling reveals declining confidence in the CDC after autism-vaccine claims were added to federal guidance, with Americans leaning toward guidance from the American Medical Association when recommendations clash.

What the organization is doing may be legal, but is it ethical?

New federal loan limits in the OBBBA threaten to increase medical school debt and worsen physician shortages, impacting diversity in health care.

CMS administrator outlines payment changes, Medicaid reforms, fraud efforts and a plan to overhaul prior authorization during his speech at the AMA Interim Meeting of the House of Delegates.

FAA cuts flights at 40 major airports amid government shutdown, threatening delays and cancellations.

New WalletHub data shows where the federal shutdown’s fallout is spreading fastest — and how long recovery could take.

Part three of our three-part webinar series airs Nov. 4 at 7 p.m. ET, unpacking how most favored nation pricing, import tariffs and direct-to-consumer channels could ripple through payer contracts, 340B and practice economics.

New JAMA analysis estimates more than 11,000 physicians on H-1B visas in FY 2024; reliance nearly doubles in rural areas and quadruples in the poorest counties.

KFF and The Washington Post surveyed more than 2,700 U.S. parents on their views of children’s health, vaccines and trust in institutions. The findings reveal what pediatricians and primary care physicians are up against — and where trust still lives.

President Trump vows to slash prices for weight-loss drugs down to $150, sparking investor concerns and renewed debate over U.S. drug pricing policy.

Joint KFF/Washington Post survey finds broad bipartisan support for food regulation — and sharp divides on vaccines and trust in public health institutions.

Patients are paying attention, but not all messages are true.

A revised CMS notice late on Oct. 15 said claims for Physician Fee Schedule and other payment programs will be processed and paid in a timely manner. The exceptions are claims for programs that have expired, such as telehealth flexibilities.

Pfizer was at the White House late last month; AstraZeneca touts expansion in Virginia.

A new KFF survey finds that while 77% of Americans heard President Trump’s claim linking Tylenol use during pregnancy to autism, most aren’t convinced.

A KFF survey shows 77% of U.S. adults heard President Trump’s claim linking Tylenol use in pregnancy to autism. Most don’t believe it.

In part two of MJH Life Sciences’ three-part series, experts dissect President Trump’s most-favored nation executive order, warning that its use of tariffs and foreign price benchmarks could upend drug markets and test the limits of federal authority.